- Nemalobuněčný karcinom plic s přestavbou genu ALK a ROS1, léčený lorlatinibem2019 | Second Faculty of Medicine
- Non-small cell lung cancer with ALK and R0S1 genes rearregement2018 | Faculty of Medicine in Pilsen
- Lorlatinib2019 | Second Faculty of Medicine
- Lorlatinib in the treatment of non-small cell lung cancer2019 | Second Faculty of Medicine